Adar1 Capital Management, LLC Portfolio Holdings
Adar1 Capital Management, LLC
- $441 Billion
- Q1 2024
Adar1 Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $441 Billion distributed in 261 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ea Series Trust with a value of $33.9B, Roivant Sciences Ltd. with a value of $29.4B, Alnylam Pharmaceuticals, Inc. with a value of $26.9B, Protagonist Therapeutics, Inc with a value of $22.7B, and Cytokinetics Inc with a value of $22.4B.
Examining the 13F form we can see an increase of $161B in the current position value, from $280B to 441B.
Adar1 Capital Management, LLC is based out at Austin, TX
Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.
Stock Holdings Table Market Cap. of $200 Billions or more
Summary
- Portfolio
- No. of Stocks 261
- Current Value $441 Billion
- Prior Value $280 Billion
- Filing
- Period Q1 2024
- Filing Date May 15, 2024
- Form Type 13F-HR
- Activity in Q1 2024
- New Purchases 119 stocks
- Additional Purchases 35 stocks
- Sold out of 0 stocks
- Reduced holdings in 44 stocks